OCUL (STOCKS)
Ocular Therapeutix, Inc.
$9.200000
+0.040000 (+0.44%)
Prev close: $9.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Pravin U. Dugel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,969.02M
- Employees
- 274
- P/E (TTM)
- -6.37
- P/B (TTM)
- 3.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.29 | $-0.33 | +0.0423 | +12.73% |
|
Sep 2025 (Q3)
|
$-0.38 | $-0.37 | -0.0060 | -1.60% |
|
Jun 2025 (Q2)
|
$-0.39 | $-0.36 | -0.0283 | -7.82% |
|
Mar 2025 (Q1)
|
$-0.38 | $-0.30 | -0.0799 | -26.62% |
Financial Statements
| Revenues | $51.95M |
| Benefits Costs and Expenses | $317.89M |
| Cost Of Revenue | $6.57M |
| Costs And Expenses | $321.97M |
| Gross Profit | $45.38M |
| Nonoperating Income/Loss | $4.08M |
| Operating Expenses | $315.39M |
| Research and Development | $197.10M |
| Other Operating Expenses | $118.30M |
| Operating Income/Loss | -$270.02M |
| Income/Loss From Continuing Operations After Tax | -$265.94M |
| Income/Loss From Continuing Operations Before Tax | -$265.94M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$265.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$265.94M |
| Net Income/Loss Available To Common Stockholders, Basic | -$265.94M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.42 |
| Diluted Earnings Per Share | -$1.42 |
| Basic Average Shares | 187,241,483 |
| Diluted Average Shares | 187,241,483 |
| Assets | $808.06M |
| Current Assets | $782.13M |
| Inventory | $3.56M |
| Other Current Assets | $778.57M |
| Noncurrent Assets | $25.93M |
| Fixed Assets | $19.68M |
| Other Non-current Assets | $6.25M |
| Liabilities | $153.75M |
| Current Liabilities | $50.81M |
| Accounts Payable | $4.15M |
| Wages | $17.97M |
| Other Current Liabilities | $28.68M |
| Noncurrent Liabilities | $102.94M |
| Equity | $654.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $654.31M |
| Liabilities And Equity | $808.06M |
| Net Cash Flow From Operating Activities | -$204.88M |
| Net Cash Flow From Operating Activities, Continuing | -$204.88M |
| Net Cash Flow From Investing Activities | -$11.88M |
| Net Cash Flow From Investing Activities, Continuing | -$11.88M |
| Net Cash Flow From Financing Activities | $561.72M |
| Net Cash Flow From Financing Activities, Continuing | $561.72M |
| Net Cash Flow | $344.96M |
| Net Cash Flow, Continuing | $344.96M |
| Comprehensive Income/Loss | -$265.94M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$265.94M |
| Other Comprehensive Income/Loss | $0.00 |